Search research articles
Contact Us
Filters
Showing results (91-100 of 96) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 96 results.
The Lancet. Infectious Diseases
|
November 28, 2024
Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial
Jaya Goswami, Jose F Cardona, Denise C Hsu, et al.
Annals of Internal Medicine
|
November 24, 2015
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial
Anita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, et al.
BMJ Open
|
January 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against <i>Salmonella</i> Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol
Margarete Paganotti Vicentine, Naina McCann, Oisin Hennigan, et al.
The Journal of Infectious Diseases
|
June 18, 2024
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults
Jaya Goswami, Abdullah H Baqui, Pablo A Doreski, et al.
The New England Journal of Medicine
|
December 13, 2023
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
Eleanor Wilson, Jaya Goswami, Abdullah H Baqui, et al.
The Journal of the American Academy of Orthopaedic Surgeons
|
October 6, 2022
Bicondylar Tibial Plateau Fractures: What Predicts Infection?
Nathan Olszewski, Givenchy Manzano, Eleanor Wilson, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 96) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 96 results.
The Lancet. Infectious Diseases
|
November 28, 2024
Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial
Jaya Goswami, Jose F Cardona, Denise C Hsu, et al.
Annals of Internal Medicine
|
November 24, 2015
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial
Anita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, et al.
BMJ Open
|
January 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against <i>Salmonella</i> Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol
Margarete Paganotti Vicentine, Naina McCann, Oisin Hennigan, et al.
The Journal of Infectious Diseases
|
June 18, 2024
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults
Jaya Goswami, Abdullah H Baqui, Pablo A Doreski, et al.
The New England Journal of Medicine
|
December 13, 2023
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
Eleanor Wilson, Jaya Goswami, Abdullah H Baqui, et al.
The Journal of the American Academy of Orthopaedic Surgeons
|
October 6, 2022
Bicondylar Tibial Plateau Fractures: What Predicts Infection?
Nathan Olszewski, Givenchy Manzano, Eleanor Wilson, et al.
Page
of 10